单细胞测序突出显示了行动性角质炎和皮肤状细胞癌的异质性和恶性进展
Dan-Dan Zou1,2, Ya-Zhou Sun3,4, Xin-Jie Li4
1Department of Dermatology, First Affiliated Hospital of Kunming Medical University, Yunnan, China.
eLife
|December 15, 2023
概括
这项研究揭示了关键的基因驱动因子和细胞亚型,从行动性角质炎 (AK) 到皮肤状细胞癌 (cSCC) 的进展. 这些发现为cSCC治疗和免疫治疗提供了新的目标.
科学领域:
- 皮肤病学 皮肤病学
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 皮肤状细胞癌 (cSCC) 是一种常见的状细胞恶性瘤.
- 行动性角质炎 (AK) 是一种癌前病变,在进展到cSCC.
- 了解cSCC发育的分子机制对于有效治疗至关重要.
研究的目的:
- 为了全面地绘制从正常皮肤到AK和侵入性cSCC的进展过程中的细胞和分子变化.
- 确定参与cSCC发育的关键驱动基因和细胞亚型.
- 探索瘤微环境 (TME) 和其与cSCC中的角质细胞的交叉声.
主要方法:
- 单细胞RNA测序 (scRNA-seq) 来自正常皮肤,AK,状细胞癌 in situ (SCCIS) 和cSCC组织的138,982个细胞.
- 差异基因表达分析 (DEGs) 用于识别关键驱动基因.
- 免疫组织化学 (IHC),免疫光 (IF) 和单细胞ATAC测序 (scATAC-seq) 用于验证.
- 功能性实验以确认基因在cSCC进展中的作用.
主要成果:
- 在SCCIS中识别不同的细胞类型和恶性基底细胞亚型,这些细胞具有改变的增殖和迁移潜力.
- 发现关键驱动基因,包括转录因子,调节AK到cSCC的进展.
- 验证基因表达变化和在增殖,亡,迁移和入侵中的功能作用.
- 对cSCC瘤微环境和质细胞-TME交叉通话的全面描述.
结论:
- 这项研究提供了从AK中cSCC进展的详细分子图谱.
- 确定了关键基因和细胞亚型,为cSCC提供了潜在的治疗点.
- 对TME的描述为开发针对cSCC的新型免疫疗法提供了基础.
相关概念视频
01:30Skin Cancer
4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K
02:21Cancers Originate from Somatic Mutations in a Single Cell
12.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K